0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

[+] Author Affiliations

Section Editor: Robin L. Travers, MD


Arch Dermatol. 2007;143(4):450. doi:10.1001/archderm.143.4.450.
Text Size: A A A
Published online

STORE-AND-FORWARD TELEDERMATOLOGY IN SKIN CANCER TRIAGE

Although store-and-forward teledermatology (SFTD) may have a diagnostic advantage when evaluating skin growths rather than generalized dermatoses, the use of SFTD as a routine tool in the daily practice at skin cancer clinics remains limited. In this multicenter longitudinal evaluation study, Moreno-Ramirez et al evaluated the clinical effectiveness, validity, and accuracy of an SFTD triage system aimed at selecting patients with suspect skin growths for skin cancer clinic evaluation. The waiting interval to attend the clinic was significantly reduced after SFTD consultation, and the pick-up rates were 2.02% for malignant melanoma and 27.94% for patients with nonmelanoma skin cancers or precancers.

See Article

AKT1 OVEREXPRESSION IN ENDOTHELIAL CELLS LEADS TO THE DEVELOPMENT OF CUTANEOUS VASCULAR MALFORMATIONS IN VIVO

Vascular malformations are the second most common endothelial neoplasm in humans. These lesions result from the failure of endothelial cell remodeling and programmed cell death, leading to abnormal persistence of blood vessels. In this observation, Perry et al demonstrate that the constitutive activation of the Akt1 oncogene in murine endothelial cells led to the development of vascular malformations and suggest that Akt1 inhibition might offer a potential avenue for systemic or topical therapy of these lesions.

See Article

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE FOR THE TREATMENT OF RECURRENT APHTHOUS STOMATITIS

Recurrent aphthous stomatitis (RAS) is a common, painful ulcerating condition that affects 20% of healthy individuals. Thalidomide is one of the few drugs found to be effective, but the adverse effect profile limits its usefulness. Pentoxifylline is a drug used in the treatment of peripheral vascular disease. Like thalidomide, it inhibits tumor necrosis factor α production without many of the potential adverse effects. In this randomized, double-blind, placebo-controlled trial, Thornhill et al demonstrated that patients with RAS who took pentoxifylline, 400 mg, 3 times daily had more ulcer-free days, lower median pain scores, and a reduction in median ulcer size, number, and severity, although only the difference with respect to ulcer size reached the level of statistical significance.

See Article

MULTIPLE MELANOMAS AFTER TREATMENT FOR HODGKIN LYMPHOMA IN A NON-DUTCH P16-LEIDEN MUTATION CARRIER WITH 2 MC1R HIGH-RISK VARIANTS

Malignant melanoma is associated with complex genetic heterogeneity. Germline mutations in the CDKN2A gene have been observed in up to 40% of melanoma-prone families, but the penetrance of these mutations varies widely. MC1R is a gene that contributes to melanoma risk in families with CDKN2A mutations. In this case report, Figl et al describe a young woman who developed 8 invasive melanomas and 6 in situ melanomas following irradiation and chemotherapy for Hodgkin lymphoma. Genetic testing revealed not only a constitutional CDKN2 mutation but also 2 high-risk MC1R variant alleles. This report demonstrates the variability of penetrance of CDKN2A mutations that may exist within the same family due to either genetic factors such as the presence of MC1R mutations or exogenous factors such as immunosuppression.

See Article

COSMETIC PERMANENT FILLERS FOR SOFT TISSUE AUGMENTATION

Permanent cosmetic fillers are generally regarded as safe and well tolerated, although a weak foreign body–type granulomatous reaction consistent with sarcoidal granulomas is a rare adverse effect. In this case report, Fischer et al describe permanent filler–associated granulomas as an inflammatory response to peginterferon alfa-2a therapy for chronic hepatitis C infection. Treatment with allopurinol was well tolerated and did not interfere with the outcome of antiviral therapy. The risk of severe interaction with interferon or other immunostimulatory medications should be included in the consent form for injectable aesthetic microimplants.

See Article

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

199 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs